On Thursday, Prime Minister Narendra Modi informed that healthcare expansion of AIIMS network from
The second wave of Covid in April-May is taking its toll on
India’s first ‘plasma bank’ for COVID-19 patients to be set up in Delhi: Kejriwal
Delhi CM Arvind Kejriwal today announced a plasma bank will be set up in Delhi for treatment of COVID-19 patients, which will be India's
India’s first COVID-19 vaccine candidate ‘COVAXIN’ approved for human trials
Hyderabad-based Bharat Biotech on Monday said its COVID-19 vaccine candidate 'COVAXIN' has received approval from the Drugs Controller General of India (DCGI) to conduct
Mamata govt fixes ₹2,250 rate for COVID-19 test at WB private labs
West Bengal CM Mamata Banerjee on Friday announced guidelines capping treatment cost of coronavirus patients at private healthcare facilities, reducing and capping the cost
AstraZeneca leading in COVID-19 vaccine race, Moderna not far behind: WHO
AstraZeneca's experimental COVID-19 vaccine is probably the world's leading candidate and most advanced in terms of development, World Health Organization's (WHO) chief scientist Soumya
AI, Mobile Technology & Medical Healthcare equipment put forth a tremendous opportunity for Health Care Services
PHD Chamber of Commerce and Industry jointly with Economic and Trade Mission, Embassy of Israel in India hosted an interactive webinar on "Digital Health:
Millions more could die if there is a 2nd COVID-19 wave: WHO official
Millions more could die if there is a second wave of coronavirus, WHO Assistant Director-General for Strategic Initiatives, Dr Ranieri Guerra, has said. "The
Early human trial of COVID-19 vaccine shows it’s effective: China’s CNBG
China National Biotec Group (CNBG) on Sunday said early human test results for its coronavirus vaccine candidate suggested it could be safe and effective.
Low-cost drug dexamethasone allowed for Covid-19 treatment in India
The government has allowed the use of the low-cost steroid drug dexamethasone as an alternative to methylprednisolone to treat coronavirus patients with moderate and